In today’s recent session, 0.54 million shares of the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have been traded, and its beta is 1.79. Most recently the company’s share price was $31.64, and it changed around $2.71 or 9.35% from the last close, which brings the market valuation of the company to $231.71M. TNXP at last check was trading at a discount to its 52-week high of $594.88, offering almost -1780.15% off that amount. The share price’s 52-week low was $6.76, which indicates that the recent value has risen by an impressive 78.63% since then. We note from Tonix Pharmaceuticals Holding Corp’s average daily trading volume that its 10-day average is 1.55 million shares, with the 3-month average coming to 1.41 million.
Tonix Pharmaceuticals Holding Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended TNXP as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Instantly TNXP has been showing a green trend so far today with a performance of 9.35% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 32.69 on recent trading dayincreased the stock’s daily price by 3.21%. The company’s shares are currently down -4.08% year-to-date, but still up 18.93% over the last five days. On the other hand, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is 77.53% up in the 30-day period. We can see from the shorts that 0.98 million shares have been sold at a short interest cover period of 1.18 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 46.06%.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp’s next quarterly earnings report is expected to be released on 2025-May-11.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.06% of Tonix Pharmaceuticals Holding Corp shares, and 7.03% of them are in the hands of institutional investors. The stock currently has a share float of 7.03%.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 31.04 shares worth $0.97 million, making up 0.42% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Total Market Index Fund held roughly 10.5 shares worth around $0.33 million, which represents about 0.14% of the total shares outstanding.
